Mannatech, Incorporated
Mannatech, Incorporated is classed by the SEC under Medicinal Chemicals & Botanical Products (industry code 2833), based in Flower Mound, TX. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $108 million and a loss of $15 million (its filed statements).
vs its business-model standard
Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a product business: prior from its industry code (SEC 2833, Medicinal Chemicals & Botanical Products); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.
The grade, in three tenses
Headline 4.4 out of ten, 8 of 9 metrics filed and 1 estimated: past 3.5 out of ten, present 4.7 out of ten, future 4.8 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.
The nine metrics
- Surviving crises (past): 2.8 out of ten. 5 warning events since 2017; the latest 2026-04-24. 28th percentile among 20 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Track record (past): 2.4 out of ten. -6.5% a year over 8 filed years; profitable in 4 of 8. 24th percentile among 18 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Shareholder treatment (past): 6.9 out of ten. CrossAssetData estimate 6.9/10, confidence 35 of 100 (one part). 69th percentile among 18 sector filers. A CrossAssetData estimate, not a filed reading: one part, confidence 35 of 100; a filing that carries the missing parts replaces this estimate with the filed reading.
- Financial health (present): 6.0 out of ten. Leverage 117%: owes 117¢ per asset dollar. 60th percentile among 20 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Industry position (present): 3.2 out of ten. bottom 32% of 18 in its family; net margin -14.1%. 32nd percentile among 18 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Leadership (present): 4.4 out of ten. bottom 44% of 12 in its family for leadership; chief executive since 2025. 44th percentile among 12 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-09).
- Room to expand (future): 5.3 out of ten. top 47% of 18 in its family for room to expand. 53rd percentile among 18 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Growth drivers (future): 5.7 out of ten. top 43% of 18 in its family for growth drivers. 57th percentile among 18 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Expectations vs reality (future): 2.6 out of ten. bottom 26% of 18 in its family for expectations against reality. 26th percentile among 18 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
The filing record
Newest annual report: Form 10-K filed 2026-04-15 for the period ended 2025-12-31 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-08-12 for the period ended 2026-06-30 (on EDGAR). Newest results release: Form 8-K filed 2026-08-12 (on EDGAR). Newest filing: Form 8-K, 2026-09-01. Filings on record since 1998. Read from EDGAR 2026-10-12.
Where the revenue comes from
Product and service lines in fiscal 2025: Product 98%, Product and Service Other 2%, Associate Service Fees under 1%. As tagged in its annual report (Form 10-K, filed 2026-04-15).
Who runs it
Fredrick, Landen Granvel (President and CEO); Haider, Yasir (Chief Financial Officer); Clavijo, James (Chief Financial Officer); Barta, Erin Kemmler (General Counsel); John, Seifrick A (director); Toth, Robert (director); Jobe, Larry A (director); Robbins, Kevin Andrew (director); Fredrick, J Stanley (director); Rameson, Tyler (director). 10 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-09-30.
This file: Overview · Past · Present · Future · Filings · every company on file
Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.